Limited utility of the HScore in detecting secondary haemophagocytic lymphohistiocytosis in COVID-19: response

Br J Haematol. 2021 Aug;194(4):688-689. doi: 10.1111/bjh.17535. Epub 2021 May 16.

Authors

Henry Wood^{1

2}, Austin G Kulasekararaj^{1

2

3}

Affiliations

¹ Department of Haematological Medicine, King's College Hospital-NHS Foundation Trust, London, UK.
² King's College London, London, UK.
³ NIHR/Wellcome King's Clinical Research Facility, London, UK.

No abstract available

Keywords: COVID-19; hyperinflammatory syndrome; immunosuppressive therapy.

Publication types

Letter
Comment

MeSH terms

COVID-19*
Cytokine Release Syndrome
Humans
Lymphohistiocytosis, Hemophagocytic* / diagnosis
SARS-CoV-2